
Pricing & Access· July 11, 2026 · 16 min read
GSK Portfolio Dossier: ViiV HIV, Nucala Runway, and Oncology Rebuild
By Ran Chen#HIV#Respiratory#Infectious Disease
Asthma, COPD, biologics, inhaled therapy, access criteria, and respiratory drug commercialization.


